121 related articles for article (PubMed ID: 35983819)
21. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.
Kachakova D; Mitkova A; Popov E; Popov I; Vlahova A; Dikov T; Christova S; Mitev V; Slavov C; Kaneva R
DNA Cell Biol; 2015 Mar; 34(3):189-200. PubMed ID: 25521481
[TBL] [Abstract][Full Text] [Related]
22. Identification of miRNA signatures and their therapeutic potentials in prostate cancer.
Karadag A; Ozen A; Ozkurt M; Can C; Bozgeyik I; Kabadere S; Uyar R
Mol Biol Rep; 2021 Jul; 48(7):5531-5539. PubMed ID: 34318435
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA expression profiles in benign prostatic hyperplasia.
Zhang N; Li Z; Bai F; Ji N; Zheng Y; Li Y; Chen J; Mao X
Mol Med Rep; 2018 Mar; 17(3):3853-3858. PubMed ID: 29359788
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
25. A potential regulatory loop between Lin28B:miR‑212 in androgen-independent prostate cancer.
Borrego-Diaz E; Powers BC; Azizov V; Lovell S; Reyes R; Chapman B; Tawfik O; McGregor D; Diaz FJ; Wang X; Veldhuizen PV
Int J Oncol; 2014 Dec; 45(6):2421-9. PubMed ID: 25201220
[TBL] [Abstract][Full Text] [Related]
26. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.
Jin W; Fei X; Wang X; Chen F; Song Y
J Immunol Res; 2020; 2020():5873056. PubMed ID: 32455140
[TBL] [Abstract][Full Text] [Related]
27. Improved Analysis of Prostate Cancer: VIM3, ATG7 and P53 Form a Complex and Activate miRNA 371a-3p.
Nohl EK; Behring J; Kameri E; Köditz B; Nestler T; Heidenreich A; VON Brandenstein M
Anticancer Res; 2023 Jun; 43(6):2407-2416. PubMed ID: 37247912
[TBL] [Abstract][Full Text] [Related]
28. FOXP3
Davidsson S; Andren O; Ohlson AL; Carlsson J; Andersson SO; Giunchi F; Rider JR; Fiorentino M
Prostate; 2018 Jan; 78(1):40-47. PubMed ID: 29105795
[TBL] [Abstract][Full Text] [Related]
29. Importance of miR-20a expression in prostate cancer tissue.
Pesta M; Klecka J; Kulda V; Topolcan O; Hora M; Eret V; Ludvikova M; Babjuk M; Novak K; Stolz J; Holubec L
Anticancer Res; 2010 Sep; 30(9):3579-83. PubMed ID: 20944140
[TBL] [Abstract][Full Text] [Related]
30. Forkhead box p3 controls progression of oral lichen planus by regulating microRNA-146a.
Wang J; Yang L; Wang L; Yang Y; Wang Y
J Cell Biochem; 2018 Nov; 119(11):8862-8871. PubMed ID: 30125971
[TBL] [Abstract][Full Text] [Related]
31. Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome.
Juracek J; Madrzyk M; Trachtova K; Ruckova M; Bohosova J; Barth DA; Pichler M; Stanik M; Slaby O
Cancer Genomics Proteomics; 2023; 20(3):308-316. PubMed ID: 37093688
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Value of Prostate-Specific Antigen Combined with Plasma miRNA-149 Expression in Patients with Prostate Cancer Based on Experimental Data and Bioinformatics.
Wang H; Yang L; Mi Y; Wang Y; Ma C; Zhao J; Liu P; Gao Y; Li P
Contrast Media Mol Imaging; 2022; 2022():6094409. PubMed ID: 35935308
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
[TBL] [Abstract][Full Text] [Related]
34. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
[TBL] [Abstract][Full Text] [Related]
35. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barceló M; Castells M; Bassas L; Vigués F; Larriba S
Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
[TBL] [Abstract][Full Text] [Related]
36. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
Daniel R; Wu Q; Williams V; Clark G; Guruli G; Zehner Z
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621736
[TBL] [Abstract][Full Text] [Related]
37. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
[TBL] [Abstract][Full Text] [Related]
38. miR-183 in prostate cancer cells positively regulates synthesis and serum levels of prostate-specific antigen.
Larne O; Östling P; Haflidadóttir BS; Hagman Z; Aakula A; Kohonen P; Kallioniemi O; Edsjö A; Bjartell A; Lilja H; Lundwall Å; Ceder Y
Eur Urol; 2015 Oct; 68(4):581-8. PubMed ID: 25556023
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
[TBL] [Abstract][Full Text] [Related]
40. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
